Redeye initiates coverage of Fable Media Group, an affiliate company with stellar financial performa...
Q3e: revenues of DKK 311m, EBIT of DKK 12m, 4% margin Small negative operational estimate revisions ...
Redeye leaves a short comment following Cinclus’ recent announcement that the manufacturing of the I...
100 patients enrolled Reduction of falls in overall study population Topline data at the end of Q1'2...
Ramlösa Shipping (”Ramlösa” eller ”bolaget”) meddelade den 27 september år 2024 att bolagets fartygs...
Redeye comments on the announcement of sales of the Nevisense device to NIH as a research tool on th...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) publicerade den 26 september 20...
The company's third largest shareholder, Rasmussengruppen, have divested its entire holding in Nekka...
Late last night, a bid for Doro at SEK 34, a bid premium of 38.
Redeye comments on the steps in the US to expand the footprint.
Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease comp...
Q3e: sales +17% EBITDA + 39% y-o-y Positive news flow incl.
Analyst Group betraktar Tellusgruppen som en väldiversifierad och stabil friskolekoncern med en robu...
Redeye comments on Iconovo’s announced rights issue of units.
Redeye comments on Modelon’s recently announced cost reduction program and organizational changes.
Ahead of Fiskars' Q3 report, due on 24 October, we trim our 2024E-26E top line by 1-2% and adjusted ...
Redeye keeps its Base Case and forecasts unchanged.
TCECUR Sweden AB (”TCECUR” eller ”Koncernen”) meddelade den 24 september år 2024 att Jacob Philipsso...
Q3 report due 24 October, we evaluate D2C potential We forecast net sales of SEK 186m, EBITA of SEK ...
Q3 report due 25 October We forecast SEK 551m net sales, SEK 83m EBITA We reiterate fair value range...